drugset / Trial / NCT05559307
Analyzing the Pharmacodynamic Substances and the Effects of Xingnaojing for Mild-to-Severe Acute Ischemic Stroke
Phase 4
Unknown
20 enrolled
Ying Gao
Beijing Chaoyang Integrative Medicine Rescue and First Aid Hospital · collab
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The main purposes of this trial are to analyze the pharmacodynamic substances and the effects of Xingnaojing for mild-to-severe acute ischemic stroke.
Timeline
- Start
- 2022-08-16
- Primary completion
- 2022-12-31
- Completion
- 2023-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Xingnaojing injection | Unknown | 20 ml | Intravenous |